Difference between revisions of "Senile dementia"

From Aging Chart
Jump to: navigation, search
(Autoloading by CXLParser)
(Autoloading by CXLParser)
 
(One intermediate revision by the same user not shown)
Line 260: Line 260:
 
(.//.)<html><!--Pop-up for: Senile plaques !Pop-up-->
 
(.//.)<html><!--Pop-up for: Senile plaques !Pop-up-->
 
<div class="1J13DNQZ3-WQRX7P-2Y3" style="display:none;">
 
<div class="1J13DNQZ3-WQRX7P-2Y3" style="display:none;">
 +
 +
  
  
Line 267: Line 269:
  
 
<h3>Senile plaques</h3>
 
<h3>Senile plaques</h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12128091">PMID: 12128091</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/12498966">PMID: 12498966</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/19228947">PMID: 19228947</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/19744735">PMID: 19744735</a><br /></div>
 
</div>(...)<!--Pop-up for: Infections  !Pop-up-->
 
</div>(...)<!--Pop-up for: Infections  !Pop-up-->
 
<div class="1J139D7TL-27QTCB7-QH" style="display:none;">
 
<div class="1J139D7TL-27QTCB7-QH" style="display:none;">
 +
 +
  
  
Line 277: Line 281:
  
 
<h3>Infections </h3>
 
<h3>Infections </h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12875814">PMID: 12875814</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/17220915">PMID: 17220915</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/15579287">PMID: 15579287</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/12220687">PMID: 12220687</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/17433562">PMID: 17433562</a><br /></div>
 
</div>(...)<!--Pop-up for: Trophic disturbances !Pop-up-->
 
</div>(...)<!--Pop-up for: Trophic disturbances !Pop-up-->
 
<div class="1J13CXN2F-1WG94Q6-1Y3" style="display:none;">
 
<div class="1J13CXN2F-1WG94Q6-1Y3" style="display:none;">
 +
 +
  
  
Line 287: Line 293:
  
 
<h3>Trophic disturbances</h3>
 
<h3>Trophic disturbances</h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22297619">PMID: 22297619</a><br /></div>
 
</div>(...)<!--Pop-up for: Lipofuscin !Pop-up-->
 
</div>(...)<!--Pop-up for: Lipofuscin !Pop-up-->
 
<div class="1J139BS6X-22MJ3GP-P7" style="display:none;">
 
<div class="1J139BS6X-22MJ3GP-P7" style="display:none;">
 +
 +
  
  
Line 297: Line 305:
  
 
<h3>Lipofuscin</h3>
 
<h3>Lipofuscin</h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12208347">PMID: 12208347</a><br /></div>
 
</div>(...)<!--Pop-up for: Proteins glycation !Pop-up-->
 
</div>(...)<!--Pop-up for: Proteins glycation !Pop-up-->
 
<div class="1J139KLKM-1LCXD42-V0" style="display:none;">
 
<div class="1J139KLKM-1LCXD42-V0" style="display:none;">
 +
 +
  
  
Line 307: Line 317:
  
 
<h3>Proteins glycation</h3>
 
<h3>Proteins glycation</h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11138929">PMID: 11138929</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/18473848">PMID: 18473848</a><br /></div>
 
</div>(...)<!--Pop-up for: Inflammation !Pop-up-->
 
</div>(...)<!--Pop-up for: Inflammation !Pop-up-->
 
<div class="1J139B985-1ZQTZHN-NJ" style="display:none;">
 
<div class="1J139B985-1ZQTZHN-NJ" style="display:none;">
 +
 +
  
  
Line 317: Line 329:
  
 
<h3>Inflammation</h3>
 
<h3>Inflammation</h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15285801">PMID: 15285801</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/12909295">PMID: 12909295</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/11391392">PMID: 11391392</a><br /></div>
 
</div>(...)<!--Pop-up for: Synapses degeneration !Pop-up-->
 
</div>(...)<!--Pop-up for: Synapses degeneration !Pop-up-->
 
<div class="1J1396FH6-21PP2DZ-JL" style="display:none;">
 
<div class="1J1396FH6-21PP2DZ-JL" style="display:none;">
 +
 +
  
  
Line 327: Line 341:
  
 
<h3>Synapses degeneration</h3>
 
<h3>Synapses degeneration</h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19390859">PMID: 19390859</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/12687639">PMID: 12687639</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/20533377">PMID: 20533377</a><br /></div>
 
</div>(...)<!--Pop-up for: Separate neuron groups  (dopaminergic, cholinergic) !Pop-up-->
 
</div>(...)<!--Pop-up for: Separate neuron groups  (dopaminergic, cholinergic) !Pop-up-->
 
<div class="1N9KPYC9B-4K0LLK-1Q6P" style="display:none;">
 
<div class="1N9KPYC9B-4K0LLK-1Q6P" style="display:none;">
 +
 +
  
  
Line 337: Line 353:
  
 
<h3>Separate neuron groups  (dopaminergic, cholinergic)</h3>
 
<h3>Separate neuron groups  (dopaminergic, cholinergic)</h3>
<div class="links"> </div>
+
<div class="links"></div>
 
</div>(...)<!--Pop-up for: Oxidative stress !Pop-up-->
 
</div>(...)<!--Pop-up for: Oxidative stress !Pop-up-->
 
<div class="1J139HFXV-1YVJ5KD-S8" style="display:none;">
 
<div class="1J139HFXV-1YVJ5KD-S8" style="display:none;">
 +
 +
  
  
Line 347: Line 365:
  
 
<h3>Oxidative stress</h3>
 
<h3>Oxidative stress</h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10880853">PMID: 10880853</a><br /></div>
 
</div>(...)<!--Pop-up for: Phenolic  Amines (NTox) !Pop-up-->
 
</div>(...)<!--Pop-up for: Phenolic  Amines (NTox) !Pop-up-->
 
<div class="1J13F7FY6-1B2SLXD-3JR" style="display:none;">
 
<div class="1J13F7FY6-1B2SLXD-3JR" style="display:none;">
 +
 +
  
  
Line 357: Line 377:
  
 
<h3>Phenolic  Amines (NTox)</h3>
 
<h3>Phenolic  Amines (NTox)</h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11371763">PMID: 11371763</a><br /></div>
 
</div>(...)<!--Pop-up for: Copper ions !Pop-up-->
 
</div>(...)<!--Pop-up for: Copper ions !Pop-up-->
 
<div class="1J13D7HX2-23RYYYV-2BF" style="display:none;">
 
<div class="1J13D7HX2-23RYYYV-2BF" style="display:none;">
 +
 +
  
  
Line 367: Line 389:
  
 
<h3>Copper ions</h3>
 
<h3>Copper ions</h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16325427">PMID: 16325427</a><br /></div>
 
</div>(...)<!--Pop-up for: Mitochondrial  Dysfunction !Pop-up-->
 
</div>(...)<!--Pop-up for: Mitochondrial  Dysfunction !Pop-up-->
 
<div class="1J139F328-1LRS67J-R7" style="display:none;">
 
<div class="1J139F328-1LRS67J-R7" style="display:none;">
 +
 +
  
  
Line 377: Line 401:
  
 
<h3>Mitochondrial  Dysfunction</h3>
 
<h3>Mitochondrial  Dysfunction</h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10961426">PMID: 10961426</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/17625988">PMID: 17625988</a><br /></div>
 
</div>(...)<!--Pop-up for: Platelet  Activating factor !Pop-up-->
 
</div>(...)<!--Pop-up for: Platelet  Activating factor !Pop-up-->
 
<div class="1J13FK5JT-1GBXCWM-442" style="display:none;">
 
<div class="1J13FK5JT-1GBXCWM-442" style="display:none;">
 +
 +
  
  
Line 387: Line 413:
  
 
<h3>Platelet  Activating factor</h3>
 
<h3>Platelet  Activating factor</h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15094513">PMID: 15094513</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/12038971">PMID: 12038971</a><br /></div>
 
</div>(...)<!--Pop-up for: Senile dementia !Pop-up-->
 
</div>(...)<!--Pop-up for: Senile dementia !Pop-up-->
 
<div class="1J13BFW49-9W6HPG-143" style="display:none;">
 
<div class="1J13BFW49-9W6HPG-143" style="display:none;">
 +
 +
  
  
Line 397: Line 425:
  
 
<h3>Senile dementia</h3>
 
<h3>Senile dementia</h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/719462">PMID: 719462</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/12752036">PMID: 12752036</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/20813206">PMID: 20813206</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/17180163">PMID: 17180163</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/19918254">PMID: 19918254</a><br /></div>
 
</div>(...)<!--Pop-up for: Myelin damage !Pop-up-->
 
</div>(...)<!--Pop-up for: Myelin damage !Pop-up-->
 
<div class="1J13CSKJN-DSN3J7-1SN" style="display:none;">
 
<div class="1J13CSKJN-DSN3J7-1SN" style="display:none;">
 +
 +
  
  
Line 407: Line 437:
  
 
<h3>Myelin damage</h3>
 
<h3>Myelin damage</h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12794739">PMID: 12794739</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/14675724">PMID: 14675724</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/14501200">PMID: 14501200</a><br /></div>
 
</div>(...)<!--Pop-up for: Quinolinic  Acid !Pop-up-->
 
</div>(...)<!--Pop-up for: Quinolinic  Acid !Pop-up-->
 
<div class="1J13DFJT7-2B8CJ4G-2LL" style="display:none;">
 
<div class="1J13DFJT7-2B8CJ4G-2LL" style="display:none;">
 +
 +
  
  
Line 417: Line 449:
  
 
<h3>Quinolinic  Acid</h3>
 
<h3>Quinolinic  Acid</h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22251552">PMID: 22251552</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/11519483">PMID: 11519483</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/15639803">PMID: 15639803</a><br /></div>
 
</div>(...)<!--Pop-up for: Microglia changes !Pop-up-->
 
</div>(...)<!--Pop-up for: Microglia changes !Pop-up-->
 
<div class="1J13D1S6Q-1MGM8YQ-219" style="display:none;">
 
<div class="1J13D1S6Q-1MGM8YQ-219" style="display:none;">
 +
 +
  
  
Line 427: Line 461:
  
 
<h3>Microglia changes</h3>
 
<h3>Microglia changes</h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15285801">PMID: 15285801</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/17180163">PMID: 17180163</a><br /></div>
 
</div>(...)<!--Pop-up for: Cerebral atherosclerosis !Pop-up-->
 
</div>(...)<!--Pop-up for: Cerebral atherosclerosis !Pop-up-->
 
<div class="1J13BLR95-19DY8FH-19Q" style="display:none;">
 
<div class="1J13BLR95-19DY8FH-19Q" style="display:none;">
 +
 +
  
  
Line 437: Line 473:
  
 
<h3>Cerebral atherosclerosis</h3>
 
<h3>Cerebral atherosclerosis</h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11913485">PMID: 11913485</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/23204143">PMID: 23204143</a><br /></div>
 
</div>(...)<!--Pop-up for: Disturbances in neocortex, hippocampus, hypothalamus, substantia nigra !Pop-up-->
 
</div>(...)<!--Pop-up for: Disturbances in neocortex, hippocampus, hypothalamus, substantia nigra !Pop-up-->
 
<div class="1J13FWZB8-1GJ6DPR-4KL" style="display:none;">
 
<div class="1J13FWZB8-1GJ6DPR-4KL" style="display:none;">
 +
 +
  
  
Line 447: Line 485:
  
 
<h3>Disturbances in neocortex, hippocampus, hypothalamus, substantia nigra</h3>
 
<h3>Disturbances in neocortex, hippocampus, hypothalamus, substantia nigra</h3>
<div class="links"> </div>
+
<div class="links"></div>
 
</div>(...)<!--Pop-up for: Injuries  !Pop-up-->
 
</div>(...)<!--Pop-up for: Injuries  !Pop-up-->
 
<div class="1J1399ZLS-1KCBBCJ-N2" style="display:none;">
 
<div class="1J1399ZLS-1KCBBCJ-N2" style="display:none;">
 +
 +
  
  
Line 457: Line 497:
  
 
<h3>Injuries </h3>
 
<h3>Injuries </h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10937919">PMID: 10937919</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/14589727">PMID: 14589727</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/15542981">PMID: 15542981</a><br /></div>
 
</div>(...)<!--Pop-up for: Hypertension  !Pop-up-->
 
</div>(...)<!--Pop-up for: Hypertension  !Pop-up-->
 
<div class="1J13CRWTB-B7X8M9-1RP" style="display:none;">
 
<div class="1J13CRWTB-B7X8M9-1RP" style="display:none;">
 +
 +
  
  
Line 467: Line 509:
  
 
<h3>Hypertension </h3>
 
<h3>Hypertension </h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16033691">PMID: 16033691</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/16945211">PMID: 16945211</a><br /></div>
 
</div>(...)<!--Pop-up for: Dopamine  Oxidation !Pop-up-->
 
</div>(...)<!--Pop-up for: Dopamine  Oxidation !Pop-up-->
 
<div class="1J139QCJ3-QG8QGF-VZ" style="display:none;">
 
<div class="1J139QCJ3-QG8QGF-VZ" style="display:none;">
 +
 +
  
  
Line 477: Line 521:
  
 
<h3>Dopamine  Oxidation</h3>
 
<h3>Dopamine  Oxidation</h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16191222">PMID: 16191222</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/17956294">PMID: 17956294</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/10917074">PMID: 10917074</a><br /></div>
 
</div>(...)<!--Pop-up for: Ischemia  !Pop-up-->
 
</div>(...)<!--Pop-up for: Ischemia  !Pop-up-->
 
<div class="1J1399SKF-2421FX1-MQ" style="display:none;">
 
<div class="1J1399SKF-2421FX1-MQ" style="display:none;">
 +
 +
  
  
Line 487: Line 533:
  
 
<h3>Ischemia </h3>
 
<h3>Ischemia </h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17659187">PMID: 17659187</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/11432121">PMID: 11432121</a><br /></div>
 
</div>(...)<!--Pop-up for: Glutamate !Pop-up-->
 
</div>(...)<!--Pop-up for: Glutamate !Pop-up-->
 
<div class="1J13D83HL-19F51S7-2CD" style="display:none;">
 
<div class="1J13D83HL-19F51S7-2CD" style="display:none;">
 +
 +
  
  
Line 497: Line 545:
  
 
<h3>Glutamate</h3>
 
<h3>Glutamate</h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11431009">PMID: 11431009</a><br /></div>
 
</div>(...)<!--Pop-up for: Amyloid  !Pop-up-->
 
</div>(...)<!--Pop-up for: Amyloid  !Pop-up-->
 
<div class="1J139BZGQ-2CD52M2-PQ" style="display:none;">
 
<div class="1J139BZGQ-2CD52M2-PQ" style="display:none;">
 +
 +
  
  
Line 507: Line 557:
  
 
<h3>Amyloid </h3>
 
<h3>Amyloid </h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12898153">PMID: 12898153</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/11136994">PMID: 11136994</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/10794847">PMID: 10794847</a><br /><a href="http://www.ncbi.nlm.nih.gov/pubmed/11391392">PMID: 11391392</a><br /></div>
 
</div>(...)<!--Pop-up for: Neurotoxic effects !Pop-up-->
 
</div>(...)<!--Pop-up for: Neurotoxic effects !Pop-up-->
 
<div class="1J13D6FDC-1KHG0XN-28Q" style="display:none;">
 
<div class="1J13D6FDC-1KHG0XN-28Q" style="display:none;">
 +
 +
  
  
Line 517: Line 569:
  
 
<h3>Neurotoxic effects</h3>
 
<h3>Neurotoxic effects</h3>
<div class="links"> </div>
+
<div class="links"></div>
 
</div>(...)<!--Pop-up for: Axons damage !Pop-up-->
 
</div>(...)<!--Pop-up for: Axons damage !Pop-up-->
 
<div class="1N9KNVRDW-5GSLT2-1PW5" style="display:none;">
 
<div class="1N9KNVRDW-5GSLT2-1PW5" style="display:none;">
 +
 +
  
  
Line 527: Line 581:
  
 
<h3>Axons damage</h3>
 
<h3>Axons damage</h3>
<div class="links"> </div>
+
<div class="links"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17369054">PMID: 17369054</a><br /></div>
</div>(.//.)(.//.)<!-- Do not edit!  -->
+
</div>(.//.)<h1>Senile dementia</h1>
 +
 
 +
<p>Senile dementia (SD) is a chronic and progressive disease that occurs in the elderly. Organic brain damage manifests as impaired mental function; behavioral disorders; and personality changes in cognition, memory, judgment, speech, emotion and thinking. SD encompasses a group of clinical syndromes and functional declines in daily life and social activities, which last for 4–6 months or more, and are mostly irreversible. Late-life dementia, in contrast to early-onset AD, can reflect damage to the brain by a wide range of vascular and nonvascular factors. to varying degrees, obesity, hypertension, diabetes, atrial fibrillation, high cholesterol, congestive heart failure, inflammatory conditions (such as lupus), obstructive sleep apnea (OSA), education, exercise, chronic stress, and depression can all alter brain architecture transiently or permanently at the cellular or macroscopic level.</p>
 +
<p>Alzheimer’s disease (AD) is a progressive type of senile dementia affecting a large number of the elderly population. The pathological hallmarks of the disease are selective neuronal loss, numerous extracellular deposits termed senile plaques, and intraneuronal neurofibrillary tangles (NFTs) in the patient’s brain. The major component of senile plaques is a 39 to 43 amino acid peptide termed b-amyloid protein (AbP), which is a proteolytic product of a large precursor glycoprotein, the amyloid precursor protein (APP). Intracerebral application of AbP caused a decrease of choline acetyl transferase activity, impairment of long term potentiation, and the memory disorder. Furthermore, conformational changes of AbP have been linked to its neurotoxicity. AbP is a hydrophobic peptide and has the intrinsic property of forming aggregates with b-pleated sheet structures. A growing number of reports suggest that b-pleated sheet-AbP aggregates are neurotoxic. The neurotoxicity of AbP and its association with conformational changes of the peptide have been suggested to imply the etiological significance in the pathogenesis of AD. </p>
 +
<p>Microglia, the resident innate immune cells in the brain, have been implicated as active contributors to neuron damage in neurodegenerative diseases, in which the overactivation and dysregulation of microglia might result in disastrous and progressive neurotoxic consequences. Pattern recognition receptors (PRRs) are tools used by microglia to identify neurotoxic stimuli and that stimulation of NADPH oxidase activity is the predominant mechanism through which microglia produce neurotoxic reactive oxygen species (ROS). Normal aging in the human brain is accompanied by increasing numbers of activated, interleukin 1β (IL-1β)-expressing microglia90 and enlarged phagocytic microglial subtypes. Several reports propose that the age-associated transformation of microglia is a reflection of a chronic, lifelong accumulation of minor insults leading to increased risk of neurodegenerative disease, such as Alzheimer’s disease.</p>
 +
(.//.)<!-- Do not edit!  -->
 
<html>
 
<html>
 
<link type="text/css" rel="stylesheet" href="/aging-chart/js/jquery.qtip.min.css" />
 
<link type="text/css" rel="stylesheet" href="/aging-chart/js/jquery.qtip.min.css" />

Latest revision as of 10:26, 2 August 2015

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Senile dementia

Senile dementia (SD) is a chronic and progressive disease that occurs in the elderly. Organic brain damage manifests as impaired mental function; behavioral disorders; and personality changes in cognition, memory, judgment, speech, emotion and thinking. SD encompasses a group of clinical syndromes and functional declines in daily life and social activities, which last for 4–6 months or more, and are mostly irreversible. Late-life dementia, in contrast to early-onset AD, can reflect damage to the brain by a wide range of vascular and nonvascular factors. to varying degrees, obesity, hypertension, diabetes, atrial fibrillation, high cholesterol, congestive heart failure, inflammatory conditions (such as lupus), obstructive sleep apnea (OSA), education, exercise, chronic stress, and depression can all alter brain architecture transiently or permanently at the cellular or macroscopic level.

Alzheimer’s disease (AD) is a progressive type of senile dementia affecting a large number of the elderly population. The pathological hallmarks of the disease are selective neuronal loss, numerous extracellular deposits termed senile plaques, and intraneuronal neurofibrillary tangles (NFTs) in the patient’s brain. The major component of senile plaques is a 39 to 43 amino acid peptide termed b-amyloid protein (AbP), which is a proteolytic product of a large precursor glycoprotein, the amyloid precursor protein (APP). Intracerebral application of AbP caused a decrease of choline acetyl transferase activity, impairment of long term potentiation, and the memory disorder. Furthermore, conformational changes of AbP have been linked to its neurotoxicity. AbP is a hydrophobic peptide and has the intrinsic property of forming aggregates with b-pleated sheet structures. A growing number of reports suggest that b-pleated sheet-AbP aggregates are neurotoxic. The neurotoxicity of AbP and its association with conformational changes of the peptide have been suggested to imply the etiological significance in the pathogenesis of AD.

Microglia, the resident innate immune cells in the brain, have been implicated as active contributors to neuron damage in neurodegenerative diseases, in which the overactivation and dysregulation of microglia might result in disastrous and progressive neurotoxic consequences. Pattern recognition receptors (PRRs) are tools used by microglia to identify neurotoxic stimuli and that stimulation of NADPH oxidase activity is the predominant mechanism through which microglia produce neurotoxic reactive oxygen species (ROS). Normal aging in the human brain is accompanied by increasing numbers of activated, interleukin 1β (IL-1β)-expressing microglia90 and enlarged phagocytic microglial subtypes. Several reports propose that the age-associated transformation of microglia is a reflection of a chronic, lifelong accumulation of minor insults leading to increased risk of neurodegenerative disease, such as Alzheimer’s disease.